SCHEMBL25462008

SCHEMBL25462008

c1ccc2c(c1)sc1cc(-c3nccc4cnccc34)ncc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.38
RAB9A P51151 3/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GPR3 P46089 1/20 0.36
GRM4 Q14833 1/20 0.33
KDM4E B2RXH2 3/20 0.33
HTT P42858 2/20 0.33
ROCK1 Q13464 1/20 0.33
CDK4 P11802 1/20 0.33
CCND1 P24385 1/20 0.33
POLB P06746 1/20 0.33
RAD52 P43351 1/20 0.33
GABRA1 P14867 2/20 0.32
MIF P14174 1/20 0.32
CLK1 P49759 1/20 0.32
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25462010 0.91 GPR3 (0.37) MAPTRAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL25461992 0.90 GABRA1 (0.38) MAPTRAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL25461854 0.90 KDM4E (0.35) MAPTRAB9AGRM4KDM4EHTT
SCHEMBL25461707 0.89 GPR3 (0.40) MAPTRAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL25461900 0.88 KDM4E (0.36) MAPTRAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL25462015 0.83 GRM4 (0.44) MAPTRAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL25462014 0.83 GRM4 (0.39) MAPTRAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL25462007 0.81 GABRA1 (0.38) MAPTRAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL25461962 0.79 MAPT (0.36) MAPTRAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL25461713 0.79 GABRA1 (0.40) MAPTRAB9AALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE OCIAD1, OCIAD2, EHD1 MAPT 2164/4885RAB9A 756/4885ALDH1A1 686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.